Institute of Cardiovascular Disease, Key Lab for Arteriosclerology of Hunan Province, University of South China, Hengyang, Hunan 421001, PR China.
Institute of Cardiovascular Disease, Key Lab for Arteriosclerology of Hunan Province, University of South China, Hengyang, Hunan 421001, PR China; Department of Operative Surgery, School of Medicine, University of South China, Hengyang, Hunan 421002, PR China.
Clin Chim Acta. 2019 Oct;497:130-136. doi: 10.1016/j.cca.2019.07.032. Epub 2019 Jul 27.
Diabetes and diabetic vascular complications are now the leading cause of death in the world. The effects of traditional medical treatment are usually limited and accompanied by many side effects, such as hypoglycemia, obesity, liver and kidney damage, and gastrointestinal adverse reactions. Thus, it is urgent to explore some new strategies for the treatment of patients with diabetes. Recently, extracellular vesicles have received increased attention because of their emerging roles of cell-to-cell communication under physiological and pathological conditions. In addition, because of their abundant existence in almost all body fluids, as well as their plentiful cargos of bioactive proteins and miRNAs they carry, extracellular vesicles have a strong potential for therapeutic and diagnostic applications in many metabolic diseases, such as obesity and insulin resistance. Here, with the aim of providing the basis for the development of new treatments for diabetes, we review current understanding of extracellular vesicles and the critical roles it has played in the onset and progression of diabetes and diabetic complications.
糖尿病及其血管并发症现已成为全球首要致死病因。传统医学治疗的效果通常较为局限,且伴有诸多副作用,如低血糖、肥胖、肝肾功能损害和胃肠道不良反应等。因此,探寻治疗糖尿病患者的新策略迫在眉睫。近年来,细胞外囊泡因其在生理和病理条件下发挥的新兴细胞间通讯作用而受到广泛关注。此外,由于细胞外囊泡广泛存在于几乎所有体液中,并且其携带大量生物活性蛋白和 miRNA 等 cargo,因此它们在肥胖和胰岛素抵抗等多种代谢性疾病的治疗和诊断应用方面具有很大的潜力。在这里,我们旨在为糖尿病新疗法的开发提供依据,综述了目前对细胞外囊泡的认识,以及其在糖尿病及其并发症发生和进展中所起的关键作用。